SIRT6 and cancer: However, SIRT6 has been implicated as a therapeutic target in diverse conditions such as cardiovascular (Saiyang et al., 2021), Alzheimer’s (Mohamad Nasir et al., 2018), cancer (Fiorentino et al., 2021), and several other age-related diseases (Zhao et al., 2020).